0001193125-23-231635.txt : 20230908 0001193125-23-231635.hdr.sgml : 20230908 20230908170201 ACCESSION NUMBER: 0001193125-23-231635 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20230903 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20230908 DATE AS OF CHANGE: 20230908 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cano Health, Inc. CENTRAL INDEX KEY: 0001800682 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39289 FILM NUMBER: 231245995 BUSINESS ADDRESS: STREET 1: 9725 NW 117TH AVENUE, SUITE 200 CITY: MIAMI STATE: FL ZIP: 33178 BUSINESS PHONE: 2034227700 MAIL ADDRESS: STREET 1: 9725 NW 117TH AVENUE, SUITE 200 CITY: MIAMI STATE: FL ZIP: 33178 FORMER COMPANY: FORMER CONFORMED NAME: Jaws Acquisition Corp. DATE OF NAME CHANGE: 20200121 8-K 1 d517594d8k.htm 8-K 8-K
false 0001800682 0001800682 2023-09-03 2023-09-03 0001800682 us-gaap:CommonClassAMember 2023-09-03 2023-09-03 0001800682 us-gaap:WarrantMember 2023-09-03 2023-09-03

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): September 8, 2023 (September 3, 2023)

 

 

 

LOGO

Cano Health, Inc.

(Exact name of registrant as specified in its charter)

 

 

Commission File Number: 001-39289

 

Delaware   98-1524224
(State or other jurisdiction
of incorporation or organization)
  (IRS Employer
Identification No.)

 

9725 NW 117th Avenue, Miami, FL   33178
(Address of principal executive offices)   (Zip Code)

(855) 226-6633

(Registrant’s telephone number, including area code)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading
Symbol(s)

 

Name of each exchange
on which registered

Class A common stock, $0.0001 par value per share   CANO   The New York Stock Exchange
Warrants to purchase one share of Class A common stock, each at an exercise price of $11.50 per share   CANO/WS   The New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 


Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Jacqueline Guichelaar resigned as a member of the Board of Directors (the “Board”) of Cano Health, Inc. (the “Company”), effective September 3, 2023. Ms. Guichelaar’s decision to resign was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices. Ms. Guichelaar had served on the Audit Committee and the Nominating & Corporate Governance Committee of the Board.

 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

        CANO HEALTH, INC.
September 8, 2023   By:  

/s/ Brian D. Koppy

      Brian D. Koppy
      Chief Financial Officer
EX-101.SCH 2 cano-20230903.xsd XBRL TAXONOMY EXTENSION SCHEMA 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink EX-101.DEF 3 cano-20230903_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 4 cano-20230903_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Cover [Abstract] Amendment Flag Amendment Flag Entity Central Index Key Entity Central Index Key Document Type Document Type Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Entity File Number Entity File Number Entity Incorporation State Country Code Entity Incorporation State Country Code Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, City or Town Entity Address, City or Town Entity Address, State or Province Entity Address, State or Province Entity Address, Postal Zip Code Entity Address, Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre Commencement Tender Offer Pre Commencement Tender Offer Pre Commencement Issuer Tender Offer Pre Commencement Issuer Tender Offer Security 12b Title Security 12b Title Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Emerging Growth Company Entity Emerging Growth Company Document And Entity Information [Table] Document And Entity Information [Table] Document And Entity Information [Line Items] Document And Entity Information [Line Items] Class of Stock [Axis] Class of Stock [Axis] Class of Stock [Domain] Class of Stock [Domain] Common Class A [Member] Common Class A [Member] Warrant [Member] Warrant [Member] EX-101.PRE 5 cano-20230903_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 6 g517594g0908221705007.jpg GRAPHIC begin 644 g517594g0908221705007.jpg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end XML 7 R1.htm IDEA: XBRL DOCUMENT v3.23.2
Document and Entity Information
Sep. 03, 2023
Document And Entity Information [Line Items]  
Amendment Flag false
Entity Central Index Key 0001800682
Document Type 8-K
Document Period End Date Sep. 03, 2023
Entity Registrant Name Cano Health, Inc.
Entity File Number 001-39289
Entity Incorporation State Country Code DE
Entity Tax Identification Number 98-1524224
Entity Address, Address Line One 9725 NW 117th Avenue
Entity Address, City or Town Miami
Entity Address, State or Province FL
Entity Address, Postal Zip Code 33178
City Area Code (855)
Local Phone Number 226-6633
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Common Class A [Member]  
Document And Entity Information [Line Items]  
Security 12b Title Class A common stock, $0.0001 par value per share
Trading Symbol CANO
Security Exchange Name NYSE
Warrant [Member]  
Document And Entity Information [Line Items]  
Security 12b Title Warrants to purchase one share of Class A common stock, each at an exercise price of $11.50 per share
Trading Symbol CANO/WS
Security Exchange Name NYSE
XML 8 d517594d8k_htm.xml IDEA: XBRL DOCUMENT 0001800682 2023-09-03 2023-09-03 0001800682 us-gaap:CommonClassAMember 2023-09-03 2023-09-03 0001800682 us-gaap:WarrantMember 2023-09-03 2023-09-03 false 0001800682 8-K 2023-09-03 Cano Health, Inc. 001-39289 DE 98-1524224 9725 NW 117th Avenue Miami FL 33178 (855) 226-6633 false false false false Class A common stock, $0.0001 par value per share CANO NYSE Warrants to purchase one share of Class A common stock, each at an exercise price of $11.50 per share CANO/WS NYSE false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.2 html 3 22 1 false 2 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.canohealth.com//20230903/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports d517594d8k.htm cano-20230903.xsd cano-20230903_def.xml cano-20230903_lab.xml cano-20230903_pre.xml g517594g0908221705007.jpg http://xbrl.sec.gov/dei/2022 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "d517594d8k.htm": { "axisCustom": 0, "axisStandard": 1, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2022": 25 }, "contextCount": 3, "dts": { "definitionLink": { "local": [ "cano-20230903_def.xml" ] }, "inline": { "local": [ "d517594d8k.htm" ] }, "labelLink": { "local": [ "cano-20230903_lab.xml" ] }, "presentationLink": { "local": [ "cano-20230903_pre.xml" ] }, "schema": { "local": [ "cano-20230903.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd", "https://xbrl.sec.gov/naics/2022/naics-2022.xsd" ] } }, "elementCount": 29, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2022": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 22, "memberCustom": 0, "memberStandard": 2, "nsprefix": "cano", "nsuri": "http://www.canohealth.com/20230903", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "div", "div", "body", "html" ], "baseRef": "d517594d8k.htm", "contextRef": "duration_2023-09-03_to_2023-09-03", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document and Entity Information", "menuCat": "Cover", "order": "1", "role": "http://www.canohealth.com//20230903/taxonomy/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "div", "div", "body", "html" ], "baseRef": "d517594d8k.htm", "contextRef": "duration_2023-09-03_to_2023-09-03", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 2, "tag": { "cano_DocumentAndEntityInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Document And Entity Information [Line Items]", "terseLabel": "Document And Entity Information [Line Items]" } } }, "localname": "DocumentAndEntityInformationLineItems", "nsuri": "http://www.canohealth.com/20230903", "presentation": [ "http://www.canohealth.com//20230903/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "cano_DocumentAndEntityInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Document And Entity Information [Table]", "terseLabel": "Document And Entity Information [Table]" } } }, "localname": "DocumentAndEntityInformationTable", "nsuri": "http://www.canohealth.com/20230903", "presentation": [ "http://www.canohealth.com//20230903/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.canohealth.com//20230903/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.canohealth.com//20230903/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.canohealth.com//20230903/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.canohealth.com//20230903/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.canohealth.com//20230903/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.canohealth.com//20230903/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.canohealth.com//20230903/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.canohealth.com//20230903/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.canohealth.com//20230903/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.canohealth.com//20230903/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.canohealth.com//20230903/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation State Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.canohealth.com//20230903/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.canohealth.com//20230903/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.canohealth.com//20230903/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.canohealth.com//20230903/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre Commencement Issuer Tender Offer", "terseLabel": "Pre Commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.canohealth.com//20230903/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre Commencement Tender Offer", "terseLabel": "Pre Commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.canohealth.com//20230903/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security 12b Title", "terseLabel": "Security 12b Title" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.canohealth.com//20230903/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.canohealth.com//20230903/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.canohealth.com//20230903/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.canohealth.com//20230903/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.canohealth.com//20230903/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Stock [Domain]", "terseLabel": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.canohealth.com//20230903/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "us-gaap_CommonClassAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Class A [Member]", "terseLabel": "Common Class A [Member]" } } }, "localname": "CommonClassAMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.canohealth.com//20230903/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]", "terseLabel": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.canohealth.com//20230903/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrant [Member]", "terseLabel": "Warrant [Member]" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.canohealth.com//20230903/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "domainItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 15 0001193125-23-231635-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-23-231635-xbrl.zip M4$L#!!0 ( $"(*%=0TZX0Y0, %L/ 1 8V%N;RTR,#(S,#DP,RYX M"ZP]X"6CK;1"E2(ZDD M_N][I"1;=AS7=H)A>0G%N^_NNQ\\TNB&A&1A;6$22N_O[Z-LQJ51HK1HP42IRBD)PT;_ MC\EW\G=E/2%C$, ,D)P9"YI\*KG(DFZGVXWCSH?H?1NF@3E[)&,6$M*G?8IZ M/1)WDW=G2?R.7'XEG[T5228\AS94%4O-YPM+?DM_)QXU5%*"$+ D5UPRF7(F MR+>&\5LRDFE$+H4@8P!BWHKW&/,%@()S$KX(R9J0?;@N1 M,JDVW+B-!3!A%[Y&+C&=?J?7@F3 5PA/RD :S=4=1<&V>2?GN\/H=CH]BBUA M,=/0@@@N?^Q!./$4NZ/MY!'DON?_/]&5PX "&^97E>*&U)U;G7*O4':D\!W%?8U"UT M6V'<#7MQA,8"(G?R?J+HA#Z;2-,.)Q%9]=+!1,Q3/>\6H5L\Y7WW23DY ]M# MP,7?=_''[P^*_]$0>0$F2MX\ETQK$IY>$\EX6@VZ:GEX7=;(9_5F,T=<'L[V M.MX>/,<'O7,@41#6-#M[P]\]SUZ:AK]Z#N;1NJAJ(IX&DU)9[[M-CA4%ES-5 M;^&F.]1)<[+',"/^ DB83K42L/^:H(56!6C+T?]Z.%0&%AIF@\!-X+"9N[>" M32.;X\:)*4) 7*_I-5C+K0-?.S%Q!: M8Q]PNU,/1VZ6>3>NWFU*UDPPNCW"ZIW-4><'7?UR]+5PQ;W=5X,)F[J.<7,6 M6^S7BE6C^==Z8O =*^ MCEM<91-O,"MUW4&2"^%<#0*K2S3*T*9FJ6V^Z8F!8L:]=W-(L"WE$P+F"7^1 M,*L25[&ULW9M;<^(V%,??.]/OH+HO[4R-N23;A0G=H;ETF.8V MA.UV^I(1]@$T*TN,)"?P[2L)BW QQ$YQ=]=/P4;G^/>7)?GXKW#V81Y3] 1" M$LZZ7J-6]Q"PD$>$3;I>(GTL0T*\#[]]_]W9#[Z/+J[ZM\A'4Z5FLA,$S\_/ MM6A,F.0T43J#K(4\#I#ON_;GPX_HKV7V#AH !2P!Q5@J$.CWA-"HTZPWFXU& M_7WMW7J8 &SRH0@KZ*!VT YTNQ9J-#LGIYW&.]2[09G_$;3;S5JVXJ8+P7Q-&;_*8L#>SIM%EHMI+^#'$(Q %.3=#2X2<\;C16"O<<'#1.=6[F^/19=, M$;7HLS$7L5T*-O6;Q+[+9H4.=*+'(HDV.W==D1[GA!'3]EH?;C2'N0(60>22 M&/S2%%LD!T5Y^$H/F#./AQ(.\>AE'"WU4+/0?>W.22T>.)"7CKU_P(ETX\W-G17]CP(_-\I%Y''-F+]V[2=?] M L@9T24#?\)"8*:*LVX%%L"4$-8F_"F(@"P)]8<7,'WPV-/S(S)SY(KB21ZH MC*"C BT7G7.=7&#:UX^&^9^PR NV)_BH@&Z!'&J6O%R;,:7@W(,@7"_9T85> M](IR;067<$,',"%2F6%\B^/!=$0JW2=Z)F1U7 I9^G>5BQH5]^MK' MV3E/].!>G/.H8">^DJH$^"&>]R,]N,B8+%\^W]+!>Y.4 -R+(@'Z>;#\8XJ= M1C'8S 3E@9[KCW=BR)]S/:P/AI<':8?:G;@7_(DLK8[BI#LYRL.]YU)A^@^9 M%9]AV1F.BFIN64\ +@*W&7-4'.,JT?LI9P77SMVXHV)]$D3IMTI3XB4L739R MO3@<"#XJX .G)-3OPVQRHP>V()CFI3D7=^-Q_IM[ M*$.9J'TI$Q#_'3@CSW%O/H2)'F.+1G,T)"J??Y ==U2LH-BID]Z<9[?T.)"SZ*NI\N@F7[#,+>DZS4]E$B- MRF>FH5W[K,?:"3E3,%>7U,[#KB=A8CZ\?$^YA*CK*9% :1V4:<\6ZK!-5Y#G M\J/R]5-)DG=-_G6]^2TY?MC"2C4V6U]:I-MU*4&E\;U6.FOU>OT+W='-[9 L MH0<ML"G6'3.86_UK["8?EVE7L\/Z?V?;74 M;CJ)JL%/'5/:B6Y46/26N>TD-ZLE>=,R=R(K5F3M MFO!.:,7JJSV.OE-;L0(K:X? 2:U8B75HI\%)KEAE]?I>A1->L>)J=_?#":U8 M3;6UI9*J/*U8)96]0>/$5K*"VK//XS3G+J'.["\UMOZGVORV9?4+#GWP+U!+ M P04 " ! B"A7-VI0WJP' "Z50 %0 &-A;F\M,C R,S Y,#-?;&%B M+GAM;,V<86_;-A"&OP_H?[AY7S:@MN.D&Q:C:>$YR1 L:8+&78<%0R'+M$-4 M(@U*3NQ_/Y*2$MFF9,H\1?G05I7NWKO7>4ZA;=KO/R[# !Z(B"AG)ZU>YZ % MA/E\0MGLI+6(VE[D4]J"*/;8Q LX(R>M%8E:'S^\^>']C^TVG)Y??((VW,?Q M/.IWNX^/CYW)E+*(!XM82D8=GX==:+>S^.'H"_R=E.O#9Q(0+R(0>E%,!/RQ MH,&D?WAP>-CK'?S>^2V?)HBG]&#BQ:0/Q]WCKHP[@MYA_]VO_=X[&%S!F59A M,*(AR:?R^4K0V7T,/_N_@,XZY8R1(" K.*?,8S[U KC-.GX+%\SOP" (X+-* MBV2;$1$/9-))50/*OO?57V/5/+SY 4 ^BBS2YTY:ZK%('XKE6 0=+F:RV8.C M;I;2>LY8;J4\'NF$WO'Q<5=?S4='U!0KQ7O=?ZXN;_U[$GIM^>C+GY:?EHEH M/]+G+[FO'T*+!J$P0OVOG86UU:EV[[!]U.LLHTGK@RJ8/CK>F 27\@BTA[[@ M 2DIK"[KZJTT/E[-93Q9QH1-2*K\I,W]-.I>D&FBJMC3DA'Q.S/^T)T0J@@Y M5 =M=: Z_$G^Y]N02]P'XR@6GA^OUPO40\1%=E*;.&D9DKKK#:FX@?#7M#SA M9SKR<(?_-*+K<_ESF\=MK9BE3P4/C5VDY;CAXK=@'!C;5"3)(S7=A+6_W.[R MF@CEC0D2\860>%7YT6H_'[0RW&7:_[WO/M=^+:W*6TA$+JOVZX;D()28RS_Q M>>#-;)'<2&H(27/KW'#1!4F#$!*23\J@I)V!K*'1/)"VW;KA>,9B&J^&LHSP M@@MY U[^15:V6!8D-X1GN15>$N2":XD@$K9)!4A+@*X!LH@SP#6VG@>Y>O]N M2)]R?Z'F9B2[MR5Y/:)@>$,$ MY9,S-CF53V>J\KB1W#"89BN\) @#58,@-K-)"9 U0!5!P[>&UHT<6_>/L5CX M3&94+9)9_,D+K8DVYS:Z5"@PPHMCW!<*)CW<=<)S!5 ED%8)=?1M6"18-X\! M\CD-R*=%.":B&L3YO$8!-AC@YNONX&YJX4*KU"&11P(6NU\#K%9-8X!ZP7PN MYESHU_1N8WF''_*%7$VOAGQ2\0:\0ZI1G.UL3&1BR4ZI=1JQ3 9>_C!&(G!9"(-1.D_EY217K5Q, HT.@IEEOB.0/<1*!3% MQ3_5?YL=@*H$UPSKUT-M-@SH[^$%$?VA/+P6(_[(]@(_G_X:L#?8,4'_'(:& M_*9D3<"K,L %J$*XL&,;*$/=S@4BYGJM=2UN!'^@S*_XE*%(XS4 7V3,1/U& M+!KZ1MV:^$\6S1*=K!KN$-1BI6P2*OA!'(<;'L5>\"^=5W_^;%9X#:-@-F4: MA+5(M#$PJ-8T!$DED*4PGQ/79Z-L *R].&Z$4@8%\:H OY[3U#8H4^-\^YK3 M)J@M'21P]>]YI8S#*7Z?:QN@+)MU U'M3 QN[CFK^,K[=EY#0!8:X.;K+F": MM9#@U.*@U;%>/*FGWSRD59IV _6KH'%,V)"'X8*E+\I$MK06)#>$;+D57A+D M F^)(!+!:058+^%,<8V-YU&NVKT;SK<\H#Z-*9M=R16WH%Y@R[(ILR&02TSP MH@@7A(O4D/A]EH=,WQG>NEK.DUNI;S=L;P11\T$D%GH[F/J(@+B>3NT7#F4* M#6%L88KOBG3!>IHZ%]$T8((]P$PZ+R. M,2@V:!Z&K7C$D2C0KFLPDG*USD=-CDJGI)(MQ^4-\1=R/;7J'8Y'- ZL7^/8 MSFMJ:5-D@)NO.RUKC%I8BYI4'*0Z:'GW-4TM_:ZM:"HT[0;J2'CJ\[:WJW#, MK9?@&TD-(6ING1LNNL!I$$(B,U6&1-J9RAH:S2-IVRW.??-LZ=]+MZ3*CFYS M;L/W3Z,17AR#<1_=UL.^EV85<'9TU]>W\9YJV3S&^WMG(1$S.35_"OX8W\O% MR-QC%3_-6"#1Z#M\Y;;XSE#W]_A*9)%83]\8RPI!4@G24DCO\=5HP_ F7V4O M&R/@>XPKRH\.C@^.-.GJS-.'BP9LDNWFG7(1ZM@BCK2,#Q]L$N6@Z?=TT\%X4Z7=/M.A9>T9?S0VK[>W*?DDC)R$9/0ZOV< M*FJO<5JVS=I,S%-6;5.S4>&E)D>5!5VWYO%!]E=IA*Q,EBVXIEXTU@TLHO;, M\^;)JHL$<92=>5Y^I2>^Z;UE, AO:[6RQ#?V3\ZY#P,.=-M#*Z([6:NLNPF(2\VP\NBG"$O M4,2"7,M#PLH [I(22)#7U/KZM[)5[!\;\J^>4-]&4)WOC<0&T39;X 4!KD ; MQ)!83I5Q(:ZAW;5-7KMZSI^0J_;OZCM'TU,T^>9->>9_4$L#!!0 ( $"( M*%?H&6KW<04 )4W 5 8V%N;RTR,#(S,#DP,U]P&ULU9M=<^(V M%(;O=V;_@^K>M#,UCB'9+DS(#B7)#M-\#;#=3F\RPCZ )K+DD42 ?U_)6"T& M0^S=;K/B@@]9Y^B\YY%D63;G'U8)1<\@).&LZX6-$P\!BWA,V*SK+:2/942( MAZ3"+,:4,^AZ:Y#>AXNW;\Y_\'UT>3VX0SZ:*Y7*3A LE\M&/"5,=)LAN')^\:[;3,!V/A# M,5;00>V@'>AZ+10V.Z=GG? 4]6[15>:%H3%)8-N4IVM!9G.%?HI^1IG5)6<, M*(4UNB8,LXA@BD8VXE_0@$4-U*,4#8V9U&%*$,\0-W*OE+"GCGF;F.#1VS=( MOW0>FY)*[!&WK;-:L]HV:;(C]L^JVPL9*Q=V&:W&15< I#F"+S^6DX*+098<;G@*F:9YTJZP G M;>UC'H7;T6,>16J=Z9$B2I!0\%&PI2H7N/4QEM6]T0<$ 5@I8#+%U8P1\,\T7 M&[)Y]^51(0=V &?8)$2-&7\.8B"FQ:;Y8A+4S)*C?SSVN9XS>A.I!(Y4,0G4 M]!(TBQT/[\:*ZG/6L]%3PIS5;>&J\>/16@A M=7 \-34Q-<=@"D) ?+-)SL&PLYCU#"LAJ_D- .KQ 0,%B?Q/(&YY>S60-?ML M%;I;LBSAYNL0+LP94RPGF2>]:)AAG&XF#J!*VI)_9Y"\X'&D&8#1V:=8ROOI M2/'HJ;8,+J4"ZS?C6\U?LO/Z[ #N"6 MJTQYDG"6*>O=0C(!48MIB?6K,SW23?GQT"W,4T=A?L9"8*;J<]PQ= 3A3M26 MWMEW0._E]7=/SSJQF7FN*9Y577_O&'V_9\?]=2 O56"9_=K0U[Y.<-M([6L% M M.!OO1;_0[KJOP.&#O(\8 2R_.],SRM^K'.;U6,11L'Z14%Y-!:+>>@/8". M5>N.+_4RKBZ]'6.',>XHL3Q/G>&YD3R$&3&;)4S=X:0RSG);!VF6"[$PSQR# M>4THW"VJ+D3+[9R%N"W" GSG&, !B[A(NT8KP:QS@B9DLV-HR\9QP>=.$O[H"++V9U%[T90+XYU]F7^8=2' M]1B7.G"6;ZD:R[;M)MN^_GHOQGQ9::OVJ+GK7+>UY%1/3]RDFIUJ[L6#X,_$ M/"#P)6CW?+C.=T^0A1RZ"?F!2X7I7R2MO]XJ]^ ZX!TY%F_3&;QF!NH)P'6 M%FT<1%@48*&YL]5D'IZB#W/.:E[-[MLY"&]?A 7HSM[29QV? F;N]RU8OG*O M]'C"$6,'41Y08GFZL[TTXI1$1!$VN]4G?$%,:-5@EEDZ2+),AL7HSB;3@P#3 M%T$OU;([$>8I2G$_G5:?88]YXBVWJ[Y(Y)Q85WFC(S1HHPSQ8.][JGJ4'021=3Y%]G M[]^=] ( !&!/E1W&3U.](/#+V>RH+=V,8G:F*^ZRT)"U#,M*18 #E0[&/E,3 MZ Y5[8R0W6S<,@/N"<\;]"? P^$PHX?'#DX@L]@C"T!I@&*2VW&_DI)V; \46/43?H96S11^QS1LG( M33!1?!D>,+:9_>/ZJFGW6)^FN:<"ZMF360:!7(E3*0NM,2!7(F^91_Q2ZB\52VQ(2N5JN4*- M2&G58-3!SX '+CLKIK^>9,.O\*[/ DIPA#3[:\#O3E-5X07,"](M$.84L<.G MTU3 1D%6CTBRV"\;#4H(.6D+9WQVXO [HH*QRTY3#E>^2\>H,"QU1D[XJ(S@ M3$;?N>,P+_P.(#>AMA"/]K$OX^5*GWD._!]N8,O.IQ)HE%@2VU!]?+K+,/F.R/62\?W@:/" MF3R"&9#!.0W8V12WN.>T;8JKLP(V;IE,.YDG.T.=AU'K1V1;TLT )D'EJ[I4 MJ7JG&0C[9V7$U02B*OI]X>GFRC7KMYE\!E)']&)=1"UZ=F"^D>]RFP]PN'\>#",K](]IELAFOVR((1%^_:0L)J,=O M3']$E'"Y0SX8^E_J[/")$L/F81"RN #2 =:D%?^; ME E[OMU@8SX1.LU;]UKAL7=::I')S3FI_5+]4;C[72+5^?7W9;%[6;QZ%H[4+'+]3 MU8.<,1#> 3G/5#/$,@KYTAQ> :INJ@WKE>G".?"'J 93J0IFX?A.@6:C;_?).%) M)&$GN@O6I5&[:9%&[;;>:+V\+;G]UFA^JP!"K3H!V]<" T?,'*DWB%G8<_9? M'L'Z!6E]J9&$79[8Y$JU1:#9+.7RJ_%\-LYB1$-$AS28+V1 ]N)G1B&B82H@ M[ X@B=3-S-DODR;S QV0A3):/""HV&1OK:&XU>%2+8RBMK48)"P$G:;X*"@[ M&%!"]YY#QV/ E'G@ F.T2"[$:-Z^S$O%FX%986 >19A52K]W MB9+V::I;,(\*I7S7*!E%RS*/C()A'&7^]+LI0EV0@ZOZYSI6PE9/FUNK0E9^ M%RJT4O##BE6#=;G"6F9P RU;>\HJ]03YH@O*!^32LS-K_.9VQL[8!0'V:B-J M!WKA:#KD9,&$*J)\9F,*Z1#N$1XH8O<@Y6+R31V?QM_OA*-8CN$*TWARP5U& M0-; LI97!X.AJ"-L"/J NJR9SI6L8ND)PT(LP-,V+,=FKJM\:NLM+".EGWWJ M./%S-%?$>5NX+O45*\=?[J?O/#-"X3 -XV,D2F4CPK-LQ-DY8B;##V^[8LQDN*)9R2 W(K._ MP$WX@];VS7J_6>_M+$_%<213*OJX@I#-W-[J'%D%PQ]82=;#OL32LFOW\H6N;1L0(Y7NT!!E3N 'T^@<";PN*UP+R5 M%%Z@I) ZJ_:8_9- ]$NH#XD1&!^,B-MB1-K,%4/".[KQ A(I,J/^PQX/6!JC M.08R.)34C_:&M.:3#G>1PUP!NP/F..VSH0&8HA]L.DCF/90Y57RM+A@P/7G0:FDVAT M&J$NAL)SH?)F?FW>5461Y\?CI<9\E7WZ+GD +,-*TL"+\@3UZ-2[+83;IL"N M (0+J5PZRN>/%TW8.L^F<4^PE\QRE#S:C\P=TTB=1?0 B0)0OR!5 .42I#K MQ@"$) ]Q:RBA*)I-\-W0D^81J5XTB)4S,@"X'VKW1@G7F]AN)+9- MH8\RU MHUEY(Q...(T/WY1@MTIP*QG:;3P(K$]XH.>5]4YG^RCS%U*&M9()5$O;";+% M$K_.XF^@0$[:VFOO[U:%PC'?E.B9E.A2J0&3;ZKTPJJ48^G\GKU;58K&W%B5 M=IY^):+$,,]A$C*E)'4 0F=#)NI\G/? 2E>G.?^, GTNOT6!_IZZ?,[:<:%_ M.N!K*4AN4+18L=HE>K-Q@A8?<[!ZQ\5;"1&>?N![Z4"*^-,4D M1>T-]_Z:XS[ [:G]-Z+=2[2;Z#R4EC(6N9=H0]@CH!7P>FJN9[W&J]W86YDW MARYH;%IMK5Y;1C>/O/NFGTA%QP<"'39T.B"_&1F\TT1\*LD==0>,^'@-JK?T MI,8+[86LHF>D<:&N/3,Q*S?U5T^?6-[BL.T!9RL?1Z:%[0.V>_-5T^=YS40LT3:O6UXCBSRTG,PLV:D M/2:VWM"#$7]"H,+TL;:Y732NM!H!HEVL#W>E& 8]U#@N$<]&_=4J&WC\60$QE^L<:AT5+@7 M[2ROXX0VU,SMT4DQ)RG4&3(A^ZKJSB;WOC>XU_U_?($\/!41G8UX_PY0EP6#,%X[YQ(D6TB%"E(%/T_! M;=3U>36ICDG-C>J72=!C4O%]P;T /;,.^A;ZH5%CGJ( /B85=-%=[F.S5]FC:Z.9LBURH1OIHR:G$6#F?49(;3' M(?/($'BGW8/V'FK@:GE$F^]P1;N2::D+/0'"1&A"SJ*!P(&"=D-/EVHG ,G MH"83"W OX<[' ?'UUCS3^N)+"JNQF5J*-_@P"+&9O ,10Z2Q\#]P>$#T)2^8 MF $.CGY_(_K@DQ"%<)#?:=]')0HO+H#4"@C!T6FQ1.>DJ"ZHT/Q/$JPU,DD+ MC3]R-K718*ST?V^&^OEO>#8O/]]46M\:M>8]-G(WD=MM(MH)U>FO 1B_B=7> M()8_6!;%.0,78CTZP,A+Q^OAE7:$6US7K4[6!PB -I\Q("Z)$E M@UA-A ,">WI"PM+N%?TGWTK[5&^2D/1TUJ'&VC1 ME_E]\4*\4S7?_O!;+EN->-\NVNY1*\SLRTVI\Z1UNZ65C\=77#8GYRL?>>D> MXYJ0(W)Q^B\6M /M<)>3E_)I9Y_)?"-D][[4:?!J7GTY>M]L_7)-\;ND(LRI+/DD.(GR> M(5^%[X^??8OPE[$/3SGR/(_>^/.Z1J[V..N0BTFQ+4KWDSY\4EU?DG&<9,,? M5]8_O7SV/U!+ P04 " ! B"A7>S=<;X$) E"@ &0 &=TWDPVWD?!_!?)"3NAKBZHEN)BH8>A+I2M'5F MJ:M*%%6MLY0H52E5BCK*$G6N.AJZ="NE32*NK3IKW31(M5M$7-7*4D(MC^X\ MQS_/'_L\[^]\9SXSG\]\9U[SF>_N^.X'8)^-A;4% *!@(M[!]A]"YP&8"(B M4!%A&!0*%16%B4D@)"7$Q2649&2E$51.EK(PYH:%Y M[#@.ASN@;H#7US8^HH/3_O8(2%145$)<0E%24E'[H/)![?\YNR\!. PP 5K! M(%5 " X"PT&[[< ! )@_X*\,^ A, 081$H3%1,?&^ O@\0 H'!0A"PL# $ MLM>-V>L#$+BPS,'C9B*R#MY0U3"$]IVL,ACJ5&VKG./0"EKG$BE>5$Q>05%I MO]HA=8S&89RNW@E] \/39\PM+*VL;9RB$NXE)R?=24K,I.0]R\_(+"LL?42LJ'_]<55WW_ 6=P:QG-;QJ:^_H[.I^ MW3,\,OJ&/38^P9F:GN'.\N;F%Q;Y?ZRN?5G?$&QN?7.! ##H7_FO+OB>2P@" M 4.@WUP@H1O?!N 0X8/'163,'*#>8;*JVG=@B%-99;6MHB@=QQ6Y2Z0A,7DT M;DJ-_XWVE^SOP>+_+]F_8?]Q<0 ),&AO>6#XWB(WMC#44F"-5\IH9#9:D&]F MGSN/L5&.:_NY1GSZZ/U=H*XT1MV.\J>>60K:::?J[!?=SFT#/IIS\C%.JI>= M'=?/F@\?):]ZF+ADERX1?)*BQBVJ*\ET.82L99C8;[(B%DJ0&W):I,?CGXAI MYFI*B)=$#0U_H#P[%2!J8$J%RRDXWSCY5!LB@*&6?RMT3,7-U;0 A&,LSAX( MRN(/I*NNL$MF7YT.E 7/JF]8;MR/>+-*R_A4P>)74J^@-TF;@=)7/(4C+_H? M?A.LE=614;/@U!2=+SN@U==.Z5U&U^G-^1J@"^?7D(9!KAQ>U(1$M?&S-B5/ MUG; +B"]1L"'MZ=)+F4>1J^>L=PA[HN.P;*;O"HG& _FBFNM86+Y,ZAA>O\2 MW7PHJ7@ *YV4\V&1X1UUOEW];#[Q B-X*3O;K92;32F!)"?8GUPVG.'^@CB6CUFV!]5$M0T0K,_U;8=+Z:8DZO MJ]\(^?8]VAE6?<8PV[W #I4BSEH''VHN?,\=]>$&6_Z>D)/Z+!#>5DFT)6MW MH+.JC 1J][@^[,H$^Q07DZ3Y5JYVA\%O/E"XQ M//=AI9LFYD,#(6N2F5 M^2-%<7(F:M/2+I" MQBP=]%CPGL14PR]T)BE^)7E')UM.[YL=UGN]XW.&=IA M_2;2[(J1?-?MLWQ88IABG9LQ?=Y*=.O+]D)/JFT%9]HU.:AEW2CHOET_VY8R M6:ZOA'UHNK%6O<7*6#K%*M2P%I>U_JY=P-7H4F65)/5&:,EL.#0*N1>E,8]\ MU.D4@8Y0W':4FG(L9Y":V<%/T7FOH>7@IHNQIQ)MAF--ESRQ_3Q:V\U#S2O3 M7AYG<6.2J+( Y8?:Q5G_L[,X#(U.>QU5^0B!?7G"(\FAT'%XO< M1AZL%XU;]C&-Z@K'=X;4CG&>KE'LM=&=S;,O>!6QD5T^^U[PVVQU9-P>Y M]"1J&+@$F^/\YE^Z4TR;]'\I'-?0WR([X4S.VY(E)DR8*+YD?>KPV$*,1S M5I=<$CEUO0:>[-1^][!C2)%F@*'S%GVQ==]F=&.D@RY030")>J)#SR;C MI'7>[X,K!M31M>6@"W5!HMSX_O<.#)=[N;Y>9@L>6G)OEU5X+:^OZV\:8R/\ MIM-B_.QR#[T-T>*F7DV/.P9#S6/2V@P?/$ZCCDVSD@+4$WIR3T" J(7E/U(_ M'L-TF 0?'2SQ!F<-;>.K MYC1B,"5"9R!354T_"%M@3Q>,X+ #TC'5R*.OLX>GG;2IU 0XWK3+H4-O MH,UQH0&_IO=9FB2^?#@AS6H])/:3+[VL)+!'*1SD[K=3S2)Y5.XVH\ MO-=V:NF)%YS16&E,,.;?^W218N2%A*'*/CAO922'U[AZF-_6[O2-:T^1CRS3 M-\JLZI8;="!P;#8657KT_*>[$B.,,J&[P"M\>+A$&)HL[WI';87$6E.ARS^: M\O"R7[G/B!_F8.(L(*5,(_P35OF3MS:[0,K)5^JHFJB0KRX)U@7H.T=Q"^W5 MC]64)<*VQ#+;59!LW;%:O\(WDD]?_B1%]IG]TW#LBKG8B]Q'UU77#$SD!;<= M^$3K$1"TU+0=O&UL4$L! A0#% @ 0(@H5S=J4-ZL!P NE4 !4 M ( ! PH &-A;F\M,C R,S Y,#-?;&%B+GAM;%!+ 0(4 Q0 M ( $"(*%?H&6KW<04 )4W 5 " >(1 !C86YO+3(P M,C,P.3 S7W!R92YX;6Q02P$"% ,4 " ! B"A73QP6T7H. .70 #@ M @ &&%P 9#4Q-S4Y-&0X:RYH=&U02P$"% ,4 " ! B"A7 M>S=<;X$) E"@ &0 @ $L)@ 9S4Q-S4Y-&